9-68378237-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_021965.4(PGM5):c.300G>A(p.Ser100Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00555 in 1,561,640 control chromosomes in the GnomAD database, including 396 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.031 ( 210 hom., cov: 27)
Exomes 𝑓: 0.0031 ( 186 hom. )
Consequence
PGM5
NM_021965.4 synonymous
NM_021965.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.520
Genes affected
PGM5 (HGNC:8908): (phosphoglucomutase 5) Phosphoglucomutases (EC 5.2.2.2.), such as PGM5, are phosphotransferases involved in interconversion of glucose-1-phosphate and glucose-6-phosphate. PGM activity is essential in formation of carbohydrates from glucose-6-phosphate and in formation of glucose-6-phosphate from galactose and glycogen (Edwards et al., 1995 [PubMed 8586438]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 9-68378237-G-A is Benign according to our data. Variant chr9-68378237-G-A is described in ClinVar as [Benign]. Clinvar id is 778427.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.52 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PGM5 | NM_021965.4 | c.300G>A | p.Ser100Ser | synonymous_variant | 2/11 | ENST00000396396.6 | NP_068800.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PGM5 | ENST00000396396.6 | c.300G>A | p.Ser100Ser | synonymous_variant | 2/11 | 2 | NM_021965.4 | ENSP00000379678.1 | ||
PGM5 | ENST00000396392.5 | c.300G>A | p.Ser100Ser | synonymous_variant | 2/8 | 1 | ENSP00000379674.1 | |||
PGM5 | ENST00000431583.1 | c.198G>A | p.Ser66Ser | synonymous_variant | 2/4 | 5 | ENSP00000394864.1 | |||
PGM5 | ENST00000604870.6 | n.655G>A | non_coding_transcript_exon_variant | 5/12 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0305 AC: 4319AN: 141708Hom.: 211 Cov.: 27
GnomAD3 genomes
AF:
AC:
4319
AN:
141708
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00822 AC: 1765AN: 214618Hom.: 79 AF XY: 0.00621 AC XY: 722AN XY: 116332
GnomAD3 exomes
AF:
AC:
1765
AN:
214618
Hom.:
AF XY:
AC XY:
722
AN XY:
116332
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00306 AC: 4343AN: 1419834Hom.: 186 Cov.: 32 AF XY: 0.00264 AC XY: 1864AN XY: 705294
GnomAD4 exome
AF:
AC:
4343
AN:
1419834
Hom.:
Cov.:
32
AF XY:
AC XY:
1864
AN XY:
705294
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0305 AC: 4331AN: 141806Hom.: 210 Cov.: 27 AF XY: 0.0301 AC XY: 2074AN XY: 68810
GnomAD4 genome
AF:
AC:
4331
AN:
141806
Hom.:
Cov.:
27
AF XY:
AC XY:
2074
AN XY:
68810
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 04, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at